RCT | Immunogenicity and safety of one-dose human papillomavirus vaccine vs. two or three doses. SPECIALTIES, 29 Sep 2022 Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS)…